Sphingotec

Developer of biomarker-based diagnostic solutions for cancer, cardiovascular, and other diseases

placeHennigsdorf, Brandenburg, Germany calendar_todayFounded 2002 groups36 employees language sphingotec.com

Registered entities

Innovation

33 patent families (19 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,830 times.

YearFilings
20149
201511
201612
20179
201812
201914
202014
202114
20228
20238
20247
20256

Social engagement

Social engagement: 2.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Brandenburg Capital, HBM Healthcare Investments, Wellington Partners Venture Capital, Think.Health.

Investor typeCountShare
Venture capital422%
Private equity211%
Accelerator & incubator16%
Other / undisclosed1161%

Recent activity

30 Jun 2026
Product launch
ELISA sphingotest® penKid®
25 Jun 2026
Product launch
AFIAS sphingotest® penKid®
16 Jun 2026
Event
Vicenza course
Coming soon